Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep Vein Thrombosis - The EINSTEIN DVT Study

NCT00440193 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3449

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thrombosis

Interventions

DRUG: Rivaroxaban (Xarelto, BAY59-7939)
DRUG: Enoxaparin followed by VKA

Sponsor

Bayer

Collaborators

[object Object]